INAB · IN8bio Inc. Common Stock
View on chartInsiders & Stakes
| Leslie W. Kreis Director | ▲ Buy | Open Market | 570,724 Shares held | 12/12/2022 | View profile |
| Aaron G.L. Fletcher Director | ▲ Buy | Open Market | 570,724 Shares held | 12/12/2022 | View profile |
| Ho William Tai-Wei President, CEO and CFO | ▲ Buy | Grant | 121,168 Shares held | 12/22/2025 | View profile |
| Lamb Lawrence EVP and CSO | ▲ Buy | Grant | 101,369 Shares held | 12/13/2023 | View profile |
| Brandt Peter C. Director | ▲ Buy | Grant | 95,181 Shares held | 12/22/2025 | View profile |
| Epperly Corinne Director | ▲ Buy | Grant | 81,967 Shares held | 12/13/2023 | View profile |
| Roemer Alan S. Director | ▲ Buy | Grant | 49,514 Shares held | 12/22/2025 | View profile |
| McCall Patrick Chief Financial Officer | ▲ Buy | Grant | 9,482 Shares held | 12/22/2025 | View profile |
| Rochlin Kate Chief Operating Officer | ▲ Buy | Grant | 9,085 Shares held | 12/22/2025 | View profile |
| Greenwood Luba Director | ▲ Buy | Open Market | 7,826 Shares held | 8/16/2022 | View profile |
| Goswami Trishna Chief Medical Officer | ▲ Buy | Grant | 6,729 Shares held | 12/13/2023 | View profile |
| Graff Jeremy R. Director | ▲ Buy | Grant | 4,549 Shares held | 12/13/2023 | View profile |
| Emily Fairbairn Director | ▼ Sell | Gift | 0 Shares held | 5/27/2026 | View profile |
Transaction History
| Emily Fairbairn | ▼ Sell | Gift | 724,637 | $0 | 5/27/2026 |
| Roemer Alan S. | ▲ Buy | Grant | 36,232 | $50K | 12/22/2025 |
| Brandt Peter C. | ▲ Buy | Grant | 72,464 | $100K | 12/22/2025 |
| McCall Patrick | ▲ Buy | Grant | 7,247 | $10K | 12/22/2025 |
| Emily Fairbairn | ▲ Buy | Grant | 724,637 | $1000K | 12/22/2025 |
| Ho William Tai-Wei | ▲ Buy | Grant | 36,232 | $50K | 12/22/2025 |
| Rochlin Kate | ▲ Buy | Grant | 7,247 | $10K | 12/22/2025 |
| Brandt Peter C. | ▲ Buy | Option Exercise | 81,967 | $15K | 4/30/2025 |
| Brandt Peter C. | ▲ Buy | Option Exercise | 81,967 | $15K | 4/30/2025 |
| Rochlin Kate | ▲ Buy | Option Exercise | 12,295 | $2K | 4/30/2025 |
| McCall Patrick | ▲ Buy | Option Exercise | 15,000 | $3K | 4/30/2025 |
| Roemer Alan S. | ▲ Buy | Option Exercise | 102,459 | $19K | 4/30/2025 |
| Roemer Alan S. | ▲ Buy | Option Exercise | 11,000 | $2K | 4/30/2025 |
| Ho William Tai-Wei | ▲ Buy | Grant | 126,582 | — | 10/4/2024 |
| Brandt Peter C. | ▲ Buy | Grant | 253,164 | — | 10/4/2024 |
| Roemer Alan S. | ▲ Buy | Grant | 126,582 | — | 10/4/2024 |
| McCall Patrick | ▲ Buy | Grant | 25,316 | — | 10/4/2024 |
| Rochlin Kate | ▲ Buy | Grant | 25,316 | — | 10/4/2024 |
| Epperly Corinne | ▲ Buy | Grant | 81,967 | — | 12/13/2023 |
| Graff Jeremy R. | ▲ Buy | Grant | 2,049 | — | 12/13/2023 |
| Roemer Alan S. | ▲ Buy | Grant | 102,459 | — | 12/13/2023 |
| Ho William Tai-Wei | ▲ Buy | Grant | 81,967 | — | 12/13/2023 |
| McCall Patrick | ▲ Buy | Grant | 20,492 | — | 12/13/2023 |
| Rochlin Kate | ▲ Buy | Grant | 12,295 | — | 12/13/2023 |
| Goswami Trishna | ▲ Buy | Grant | 4,098 | — | 12/13/2023 |
| Lamb Lawrence | ▲ Buy | Grant | 1,639 | — | 12/13/2023 |
| Brandt Peter C. | ▲ Buy | Grant | 81,967 | — | 12/13/2023 |
| Graff Jeremy R. | ▲ Buy | Open Market | 2,500 | $2K | 9/13/2023 |
| McCall Patrick | ▲ Buy | Open Market | 1,000 | $1K | 8/25/2023 |
| Ho William Tai-Wei | ▲ Buy | Open Market | 23,800 | $25K | 8/24/2023 |
| Emily Fairbairn | ▼ Sell | Other | 4,111,958 | $0 | 7/28/2023 |
| Leslie W. Kreis | ▲ Buy | Open Market | 9,214 | $23K | 12/12/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 57,052 | $141K | 12/12/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 8,735 | $22K | 12/12/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 9,214 | $23K | 12/12/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 57,052 | $141K | 12/12/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 8,735 | $22K | 12/12/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 3,070 | $6K | 9/28/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 19,017 | $38K | 9/28/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 2,913 | $6K | 9/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 3,070 | $6K | 9/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 19,017 | $38K | 9/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 2,913 | $6K | 9/28/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 4,912 | $10K | 8/29/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 30,428 | $61K | 8/29/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 4,660 | $9K | 8/29/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 4,912 | $10K | 8/29/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 30,428 | $61K | 8/29/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 4,660 | $9K | 8/29/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,377 | $3K | 8/26/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 8,531 | $17K | 8/26/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,306 | $3K | 8/26/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,377 | $3K | 8/26/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 8,531 | $17K | 8/26/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,306 | $3K | 8/26/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 6,142 | $12K | 8/17/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 38,035 | $73K | 8/17/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 5,823 | $11K | 8/17/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 6,142 | $12K | 8/17/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 38,035 | $73K | 8/17/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 5,823 | $11K | 8/17/2022 |
| Rochlin Kate | ▲ Buy | Open Market | 5,263 | $10K | 8/16/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,349,218 | $2.6M | 8/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,349,218 | $2.6M | 8/16/2022 |
| McCall Patrick | ▲ Buy | Open Market | 5,263 | $10K | 8/16/2022 |
| Roemer Alan S. | ▲ Buy | Open Market | 26,315 | $50K | 8/16/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 217,891 | $414K | 8/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 217,891 | $414K | 8/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 206,575 | $392K | 8/16/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 206,575 | $392K | 8/16/2022 |
| Ho William Tai-Wei | ▲ Buy | Open Market | 26,315 | $50K | 8/16/2022 |
| Goswami Trishna | ▲ Buy | Open Market | 2,631 | $5K | 8/16/2022 |
| Lamb Lawrence | ▲ Buy | Open Market | 526 | $999 | 8/16/2022 |
| Greenwood Luba | ▲ Buy | Open Market | 526 | $999 | 8/16/2022 |
| Brandt Peter C. | ▲ Buy | Open Market | 105,263 | $200K | 8/16/2022 |
| Emily Fairbairn | ▲ Buy | Open Market | 789,473 | $1.5M | 8/16/2022 |
| Lamb Lawrence | ▲ Buy | Option Exercise | 26,204 | $28K | 5/5/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
IN8bio Reports Inducement Grant Under Nasdaq Rule
IN8bio disclosed an inducement grant in compliance with Nasdaq Listing Rule 5635(c)(4). This filing is a standard corporate governance procedure used to attract or retain key employees. The stock is currently trading near its 52-week high, with technical indicators showing recent support rejection.
IN8bio Reports Inducement Grant Under Nasdaq Rule. IN8bio disclosed an inducement grant in compliance with Nasdaq Listing Rule 5635(c)(4). This filing is a standard corporate governance procedure used to attract or retain key employees. The stock is currently trading near its 52-week high, with technical indicators showing recent support rejection.